Antiviral soothing nasal wash agent

Abstract

The invention relates to an antiviral soothing nasal wash agent, and belongs to the technical field of pharmaceutical preparations. The problem of discomfort of patients due to irritation of nasal mucosa caused by existing nasal sprays is solved. The antiviral and soothing nasal wash agent is prepared from the following effective pharmaceutical components: 1-10mg / mL of seaweed polysaccharide, 5-12mg / mL of natural sea salt, 5-15mg / mL of angelica dahurica extracts and 0.1-1mg / mL of a humectant, and a solvent is sterile water for injection. According to the antiviral soothing nasal wash agent, the seaweed polysaccharide added can be cross-linked to form a net structure, a layer of moisturizing mucosa is formed, the dryness of a nasal cavity is alleviated, meanwhile a barrier can be provided to resist external toxic and harmful substances, and the spread and propagation of cold virus can be prevented. The natural sea salt has no irritating effect on the nasal cavity so that the nasal cavity can be kept clean and moist, and the symptoms of stuffy nose and dry nose can be relieved. The angelica dahurica extracts have the effect of orifice freeing pain relieving, and the symptom of the stuffy nose can be improved.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, in particular to an antiviral soothing nasal rinse. Background technique [0002] Rhinitis refers to inflammation of the nasal mucosa and submucosal tissues, manifested as congestion or edema, and patients often experience symptoms such as nasal congestion, runny nose, nasal itching, throat discomfort, and coughing. Rhinoviruses are the main pathogenic microorganisms that cause rhinitis and the main pathogenic agents of the common cold. Common treatment forms for rhinovirus infection include the use of western medicine antibiotics and histamines for treatment, but the use of western medicine is prone to drug resistance and has high toxic and side effects; Therefore, it is slow to take effect and cannot quickly treat rhinitis symptoms. [0003] Spray is a new type of nasal administration dosage form developed in recent years. It refers to the type of drug-containing solution,...

AI Technical Summary

Problems solved by technology

[0004] In order to solve the problem that existing nasal cavity sprays cause irritation to nasal mucosa and cause discomfort to patients, the present invention provides an antiviral soothing nasal rinse